Dr. Donna Nolan, DO
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,026 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $419.77 | 21 | $0 (2024) |
| Novo Nordisk Inc | $301.26 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $158.41 | 8 | $0 (2024) |
| Exact Sciences Corporation | $117.53 | 5 | $0 (2024) |
| PFIZER INC. | $103.48 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $91.85 | 5 | $0 (2023) |
| GlaxoSmithKline, LLC. | $82.91 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $75.55 | 4 | $0 (2024) |
| Lilly USA, LLC | $74.64 | 4 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $59.29 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $785.19 | 41 | ABBVIE INC. ($285.31) |
| 2023 | $505.96 | 28 | Novo Nordisk Inc ($98.14) |
| 2022 | $625.42 | 35 | Novo Nordisk Inc ($171.90) |
| 2021 | $109.88 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($38.11) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.37 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes Care | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Oncology | ||||||
| 09/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: PAIN | ||||||
| 09/27/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Biological | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes Care | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Oncology | ||||||
| 07/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Biological | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: VACCINES | ||||||
| 06/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,201 | 1,650 | $273,670 | $64,955 |
| 2022 | 18 | 820 | 1,124 | $188,504 | $56,528 |
| 2021 | 7 | 189 | 212 | $31,386 | $15,157 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 325 | 612 | $142,018 | $26,564 | 18.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 258 | 258 | $58,566 | $12,809 | 21.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $6,820 | $6,219 | 91.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 77 | 77 | $10,010 | $5,539 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 141 | $25,860 | $5,252 | 20.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 81 | 81 | $6,075 | $2,390 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,074 | $1,827 | 22.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 28 | 31 | $5,270 | $1,073 | 20.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 27 | 58 | $1,798 | $940.76 | 52.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $1,725 | $678.73 | 39.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 56 | $2,744 | $539.55 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 60 | 63 | $2,394 | $500.00 | 20.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 123 | 141 | $987.00 | $310.20 | 31.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 15 | 16 | $496.00 | $259.20 | 52.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 49 | $833.00 | $54.47 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 465 | $99,552 | $23,168 | 23.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 128 | 128 | $29,056 | $9,933 | 34.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 19 | 19 | $5,890 | $5,303 | 90.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $8,792 | $3,250 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $11,180 | $2,870 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 29 | $8,719 | $2,515 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 50 | $7,622 | $2,371 | 31.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 41 | 41 | $2,000 | $1,725 | 86.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 45 | $3,375 | $1,283 | 38.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,770 | $688.35 | 38.9% |
About Dr. Donna Nolan, DO
Dr. Donna Nolan, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2018. The National Provider Identifier (NPI) number assigned to this provider is 1649776311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Nolan, DO has received a total of $2,026 in payments from pharmaceutical and medical device companies, with $785.19 received in 2024. These payments were reported across 110 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,026).
As a Medicare-enrolled provider, Nolan has provided services to 2,210 Medicare beneficiaries, totaling 2,986 services with total Medicare billing of $136,641. Data is available for 3 years (2021–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Albany, NY
- Active Since 04/02/2018
- Last Updated 07/08/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1649776311
Products in Payments
- UBRELVY (Drug) $157.28
- XIFAXAN (Drug) $138.62
- NURTEC ODT (Drug) $125.15
- Cologuard Collection Kit (Device) $117.53
- QULIPTA (Drug) $105.97
- VRAYLAR (Drug) $78.87
- SYNTHROID (Drug) $77.65
- MOUNJARO (Drug) $74.64
- Rybelsus (Drug) $65.37
- FARXIGA (Drug) $60.61
- Kerendia (Drug) $59.29
- Ozempic (Drug) $57.28
- LEQVIO (Drug) $57.09
- FREESTYLE LIBRE 3 (Device) $52.77
- ELIQUIS (Drug) $42.79
- Wegovy (Drug) $42.61
- Veozah (Drug) $38.02
- ACCRUFER (Drug) $35.24
- Xhance (Drug) $35.08
- ENTRESTO (Drug) $34.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
Dr. Erica Parrotta, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $111,723
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736